Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Life Science REIT secures renewed lease at Herbrand Street

(Sharecast News) - Life Science REIT said on Tuesday that fintech firm Thought Machine has renewed its commitment to its Herbrand Street property in London's 'Knowledge Quarter', signing a new seven-year lease as sole occupier of the building. The London-listed real estate investment trust said the lease, covering 68,600 square feet, had been agreed at a headline rent of £75 per square foot, in line with June estimated rental value, and included an upward-only review after the fourth year.

"Thought Machine's decision to extend their commitment at Herbrand Street is a testament to the distinctive nature of the building as well as its prime location in London's Knowledge Quarter," said Simon Farnsworth, managing director at Ironstone Asset Management, Life Science REIT's investment adviser.

Life Science REIT said the agreement also provided for a 16.5-month rent-free period and had been approved by the company's lending banks.

"We are delighted to agree a new lease at Herbrand Street with the support of Life Science REIT," commented Matt Wilkins, chief people officer at Thought Machine.

"This iconic London HQ gives our team the optimal environment to continue developing market-leading banking technology as we maintain our strong upwards growth trajectory."

Herbrand Street, a grade II listed building, was acquired by Life Science REIT in May 2022 and sits close to institutions including UCL, UCH and Great Ormond Street Hospital.

At 1429 BST, shares in Life Science REIT were up 2.06% at 39.6p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.